A Review of Outcome Data concerning Children Born following Assisted Reproductive Technologies

Neonatal outcomes of Offspring Conceived through in Vitro Fertilization

There has been a dramatic rise in the use of Assisted Reproductive Technologies (ART), including In Vitro Fertilization (IVF) throughout the world over the past three decades. Because they represent >1% of the birth cohorts in many developed countries, much attention is being paid to the health and well-being of ART children. Children born after assisted reproductive techniques (ART) have an in...

Remifentanil versus Fentanyl for Assisted Reproductive Technologies :Effect on Hemodynamic Recovery from Anesthesia and Outcome of ART Cycles

Imprinting disorders after assisted reproductive technologies.

PURPOSE OF REVIEW To assess the evidence of an increased risk of imprinting diseases in children born after use of assisted reproductive technologies. RECENT FINDINGS Imprinting disorders occur when the epigenetic programming during gametogenesis is disturbed, or when this programming is not sufficiently sustained during the process of fertilization and early embryonic development. Ten case o...

Pmn-19: A Comparison of Neonatal Outcomes following Transfer of Frozen and Fresh Embryo

Background: Currently, frozen embryo transfers contribute an increasing rate of births from assisted reproductive technologies such as in vitro fertilization (IVF). However, very few studies evaluated the neonatal outcomes from frozen embryo transfer. This study aimed to investigate and compare the neonatal outcomes from frozen embryo transfer versus fresh embryo transfers. Materials and Method...

Cabergoline versus Coasting in the Prevention of Ovarian Hyperstimulation Syndrome and Assisted Reproductive Technologies Outcome in High Risk Patients

Background Coasting is the most common method used in the prevention of ovarian hyperstimulation syndrome (OHSS) acting through vascular endothelial growth factor (VEGF) reduction. However, the pregnancy rate is reported to fall with coasting when it takes more than three days. Recently lowdose cabergoline, a selective D2 dopamine receptor agonist has been proven to selectively reduce vascular ...